Neumann, M., & Hofmann, W. (2013). FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLOS ONE, 8(1), . https://doi.org/10.1371/journal.pone.0053190
Chicago-Zitierstil (17. Ausg.)Neumann, Martin, und Wolf-Karsten Hofmann. "FLT3 Mutations in Early T-cell Precursor ALL Characterize a Stem Cell like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors." PLOS ONE 8, no. 1 (2013). https://doi.org/10.1371/journal.pone.0053190.
MLA-Zitierstil (9. Ausg.)Neumann, Martin, und Wolf-Karsten Hofmann. "FLT3 Mutations in Early T-cell Precursor ALL Characterize a Stem Cell like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors." PLOS ONE, vol. 8, no. 1, 2013, https://doi.org/10.1371/journal.pone.0053190.